Frontiers in Cardiovascular Medicine·6 SepAbnormal "Escherichia Shigella-EAT-LAAD" axis in HFrEF patients with AF and the regulatory effect of SGLT2 inhibitorsNon-randomised trial in peopleSGLT2 inhibitorsPaper